Your browser doesn't support javascript.
loading
Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis.
Nziza, Nadege; Cizmeci, Deniz; Davies, Leela; Irvine, Edward B; Jung, Wonyeong; Fenderson, Brooke A; de Kock, Marwou; Hanekom, Willem A; Franken, Kees L M C; Day, Cheryl L; Ottenhoff, Tom H M; Alter, Galit.
Afiliação
  • Nziza N; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Cizmeci D; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Davies L; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Irvine EB; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, United States.
  • Jung W; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Fenderson BA; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States.
  • de Kock M; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Hanekom WA; Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States.
  • Franken KLMC; South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Day CL; Africa Health Research Institute, Durban, South Africa.
  • Ottenhoff THM; Division of Infection and Immunity, University College London, London, United Kingdom.
  • Alter G; Department of Infectious Disease, Leiden University, Leiden, Netherlands.
Front Immunol ; 14: 1329784, 2023.
Article em En | MEDLINE | ID: mdl-38077391
[This corrects the article DOI: 10.3389/fimmu.2022.856906.].
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos